Literature DB >> 1361342

Determination of extracellular glutamate after local K+ stimulation in the striatum of non-anaesthetised rats after treatment with dopaminergic drugs--studies using microdialysis.

S Dietze1, K Kuschinsky.   

Abstract

The present experiments were performed in order to investigate the effects of dopamine(DA)ergic drugs on the concentrations of extracellular glutamate (GLU) in the striatum of non-anaesthetised, freely moving rats by using microdialysis and to get further information about the interactions between glutamatergic and dopaminergic pathways. GLU was determined after pre-column derivatisation with o-phthaldialdehyde by HPLC and fluorescence detection. For increasing the fraction of extracellular GLU which is of neuronal origin, an enhanced release of this neurotransmitter was evoked by 100 mM K+ administered via the dialysis probe. This stimulation was applied twice in each experiment, at the second time after administration of a subcutaneously (s.c.) given DAergic drug. For basal conditions, a perfusion fluid containing 148.2 mM Na+, 4mM K+, 1.2 mM Ca2+ was used, for conditions of stimulation with 100 mM K+ the Na+ concentration was reduced correspondingly. Activation of the D1 receptor with the selective D1 sector agonist SKF 38393 ((+/-) 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol) 15 mg/kg) failed to influence the stimulated release of GLU, and neither a combination of the selective D2 antagonist (-)sulpiride (150 mg/kg) with the mixed D1/D2 agonist apomorphine (1 mg/kg), nor a combination of sulpiride (150 mg/kg) with SKF 38393 (15 mg/kg) were effective. Also the two selective D2 agonists quinpirole (0.5 mg/kg) or talipexole (50 micrograms/kg) had no significant influence on the release of GLU. The results suggest that DA receptor agonists have less effect on the K(+)-stimulated GLU-release than might be expected from in vitro studies or behavioral experiments (Kornhuber and Kornhuber, 1986).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1361342     DOI: 10.1007/bf01250513

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  22 in total

Review 1.  Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease.

Authors:  M Carlsson; A Carlsson
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

2.  Biphasic effect of D-2 agonist quinpirole on locomotion and movements.

Authors:  D Eilam; H Szechtman
Journal:  Eur J Pharmacol       Date:  1989-02-28       Impact factor: 4.432

3.  Selective stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933, respectively.

Authors:  N E Andén; K Gołembiowska-Nikitin; U Thornström
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-11       Impact factor: 3.000

Review 4.  Two dopamine receptors: biochemistry, physiology and pharmacology.

Authors:  J C Stoof; J W Kebabian
Journal:  Life Sci       Date:  1984-12-03       Impact factor: 5.037

5.  Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.

Authors:  A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor.

Authors:  K Tsuruta; E A Frey; C W Grewe; T E Cote; R L Eskay; J W Kebabian
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

7.  Characterization of in vivo dopamine release as determined by brain microdialysis after acute and subchronic implantations: methodological aspects.

Authors:  B H Westerink; J B De Vries
Journal:  J Neurochem       Date:  1988-09       Impact factor: 5.372

8.  The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats.

Authors:  A Imperato; A Mulas; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1987-10-06       Impact factor: 4.432

9.  Dopamine-acetylcholine interaction in the striatum studied by microdialysis in the awake rat: some methodological aspects.

Authors:  B H Westerink; P de Boer; G Damsma
Journal:  J Neurosci Methods       Date:  1990-09       Impact factor: 2.390

10.  Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.

Authors:  T Zetterström; T Sharp; U Ungerstedt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-10       Impact factor: 3.000

View more
  2 in total

1.  Overview of microdialysis.

Authors:  T S Shippenberg; A C Thompson
Journal:  Curr Protoc Neurosci       Date:  2001-05

2.  Overview of brain microdialysis.

Authors:  Vladimir I Chefer; Alexis C Thompson; Agustin Zapata; Toni S Shippenberg
Journal:  Curr Protoc Neurosci       Date:  2009-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.